Transdermal drug delivery system: An overview

Main Article Content

Vaibhav Rastogi
Pragya Yadav


Transdermal drug delivery system (TDDS) is one of the systems lying under the category of controlled drug delivery, in which the aim is to deliver the drug through the skin in a predetermined and controlled rate. It has various advantages,like prolonged therapeutic effect, reduced side-effects, improved bioavailability, better patient compliance and easy termination of drug therapy. The stratum corneum is considered as the rate limiting barrier in transdermal permeation of most molecules.There are three main routes of drug penetration, which include the appendageal, transcellular and intercellular routes. Skin age,
condition, physicochemical factors and environmental factors are some factors that are to be considered while delivering drug through this route. Basic components of  TDDS include polymer matrix, membrane, drug, penetration enhancers, pressure-sensitive adhesives, backing laminates, release liner, etc.Transdermal patches can be divided into various systems like reservoir
system, matrix system and micro-reservoir system, which are used to incorporate the active ingredients into the circulatory system via the skin.After preparation of transdermal patches, consistent methodology are adopted to test the adhesion properties,physicochemical properties, in vitro drug release studies, in vitro skin permeation studies, skin irritation studies and stability studies. According to the duration of therapy, various drugs are commercially available in the form of transdermal patches.


Download data is not yet available.

Article Details

How to Cite
Rastogi, V., & Yadav, P. (2014). Transdermal drug delivery system: An overview. Asian Journal of Pharmaceutics (AJP), 6(3).


Tiwary AK, Sapra B, Jain S. Innovation in transdermal drug delivery:

Formulation and techniques. Recent Pat Drug Deliv Formul 2007;1:23-36.

Chong S, Fung HL, In: Hadgraft J, Guy RH, editors. Transdermal drug

delivery. development issues and research initiatives. New York: Marcel

Dekker; 1989. p. 135-54.

Singh A, Singh MP, Alam G, Patel R, Vishvakarma D, Datt N. Expanding

opportunities for transdermal delivery systems: An overview. J Pharm

Res 2011;4:1417-20.

Ansel HC, Allen LV and Popovich NG. Pharmaceutical dosage forms

and drug delivery system. 7th ed. New York: Lipponcott Williams and

Wilkins; 2002.

Patel RP, Baria AH. Formulation and evaluation consideration of

transdermal drug delivery system. Int J Pharm Res 2011;3:1-9.

Kumar JA, Pullakandam N, Prabu SL, Gopal V. Transdermal drug delivery system: An overview. Int J Pharm Sci Rev Res 2010;3:49-54.

Jain NK. Advances in controlled and novel drug delivery. 1st ed.

New Delhi: CBS Publishers and Distributors; 2001. p. 108-10.

Soni M, Kumar S, Gupta GD. Transdermal drug delivery: A novel

approach to skin permeation. J Pharm Res 2009;2:1184-90.

Naik A, Kalia YN, Guy RH. Transdermal drug delivery: Overcoming the

skin’s barrier function. Pharm Sci Technol Today 2009;3:318-26.

Chandrashekhar NS, Shobha R. Physicochemical and pharmacokinetic

parameters in drug selection and loading for transdermal drug delivery.

Indian J Pharm Sci 2008;70:94-5.

Merkle HP. Transdermal delivery systems. Methods Find Exp Clin

Pharmacol 1989;11:135-53.

Brown L and Langer R. Transdermal delivery of drugs. Annu Rev Med


Arunachalam A, Karthikeyan M, Kumar DV, Prathap M, Sethuram S,

Kumar AS. Transdermal drug delivery system: A review. Curr Pharma

Res 2010;1:70-81.

Flynn GL. Percutaneous Absorption. 3rd ed. New York: Marcel Dekker;

Hadgraft J. Skin Deep. Eur J Pharm Biopharm 2004;58:291-9.

Singh MC, Naik AS, Sawant SD. Transdermal drug delivery systems

with major emphasis on Transdermal Patches: A review. J Pharm Res


Aulton ME. Aulton’s Pharmaceutics The design and manufacture of

medicine. 3rd ed. Churchill Livingstone: Elsevier; 2007. p. 567-8.

Jain NK. Controlled and Novel Drug Delivery. New Delhi: CBS Publishers and Distributors; 2002. p. 107.

Kumar TS, Selvam RP, Singh AK. Transdermal drug delivery systems for antihypertensive drugs. Int J Pharm Biomed Res 2010;1:1-8.

Chien YW. Novel drug delivery systems, Drugs and the Pharmaceutical

Sciences, Vol. 50. New York: Marcel Dekker; 1992. p. 797.

Sugibayashi K, Morimoto Y. Polymers for transdermal drug delivery

systems. J Control Release 1994;29:177-85.

Hadgraft J, Guy RH. Transdermal Drug Delivery. 2nd ed. New York:

Marcel Dekker; 1989.

Keleb E, Sharma RK, Mosa EB, Aljahwi A. Transdermal drug delivery

system and evaluation. Int J Adv Pharm Sci 2010;1:201-11.

Spencer TS, Smith SE, Conjeevaram S. Adhesive interactions between

polymers and skin in transdermal delivery systems. Polym Mater: Sci

Eng 1990;63:337-9.

Minghetti P, Cilurzo F, Tosi L, Casiraghi A, Montanari L. Design of a new

water-soluble pressure-sensitive adhesive for patch preparation. AAPS

Pharm Sci Tech 2003;4:9.

Tyle P. Drug Delivery device. 3rd ed. New York and Basel: Marcel Dekker;

Pfister WR, Sieh DS. Permeation Enhancer compatible with transdermal

drug delivery systems. Part I: Selection and Formulation consideration.

Med Device Technol 1990;1:48-55.

Godbey KJ. Improving patient comfort with non-occlusive transdermal

backings. AAPS Pharm Sci Tech 1996;1-2.

Walters KA. Transdermal drug delivery system In: Swarbick K, Boylan JC, editors. Encyclopedia of Pharmaceutical Technology. New York: Marcel Dekker; 1997. p. 253-93.

Foco A, Hadziabdic J, Becic F. Transdermal Drug Delivery Systems. MedArch 2004;58:230-4.

Sakalle P, Dwivedi S, Dwivedi A. Design, evaluation, parameters and

marketed products of transdermal patches: A review. J Pharm Res


Brahmankar DM, Jaiswal SB. Biopharmaceutics and pharmacokinetics

A treatise. Delhi: Vallabh Prakashan; 1995. p. 335-71.